No idea how that all works, but I think the CEO mentioned in interview they were being tested against various types of pain models. And of course you have epilepsy work which has also shown to be very positive in their trials. I can imagine drug development and Human trials to treat all these various medical indications would take multiple paths, many various human clinicals and would likely include various interested BP.
News 
Market Data 
Discover 
